Listed

Opus Genetics, Inc.

IRDNasdaqCIK 1228627HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$755.0k, Q2 FY2026
Operating income−$16.5m, Q2 FY2026
Net income−$8.1m, Q2 FY2026
Opus Genetics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m11.9Revenue, Q3 FY2023, three months to 2023-09-30$11.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001140361-24-046045.Report this figure1.7Revenue, Q4 FY2023, three months to 2023-12-31$1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-31, accession 0001140361-25-011410. Derived: 12-month figure less the 9-month figure.Report this figure1.7Revenue, Q1 FY2024, three months to 2024-03-31$1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001140361-25-019266.Report this figure1.1Revenue, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-13, accession 0001140361-25-030836.Report this figure3.9Revenue, Q3 FY2024, three months to 2024-09-30$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure4.3Revenue, Q4 FY2024, three months to 2024-12-31$4.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001140361-26-009247. Derived: 12-month figure less the 9-month figure.Report this figure4.4Revenue, Q1 FY2025, three months to 2025-03-31$4.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure2.9Revenue, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure3.1Revenue, Q3 FY2025, three months to 2025-09-30$3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure3.9Revenue, Q4 FY2025, three months to 2025-12-31$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001140361-26-009247. Derived: 12-month figure less the 9-month figure.Report this figure2.2Revenue, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure0.8Revenue, Q2 FY2026, three months to 2026-06-30$755.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m6.4Operating income, Q3 FY2023, three months to 2023-09-30$6.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001140361-24-046045.Report this figure(5.4)Operating income, Q4 FY2023, three months to 2023-12-31−$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001140361-25-011410. Derived: 12-month figure less the 9-month figure.Report this figure(7.7)Operating income, Q1 FY2024, three months to 2024-03-31−$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001140361-25-019266.Report this figure(8.3)Operating income, Q2 FY2024, three months to 2024-06-30−$8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001140361-25-030836.Report this figure(8.0)Operating income, Q3 FY2024, three months to 2024-09-30−$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure(38.0)Operating income, Q4 FY2024, three months to 2024-12-31−$38.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001140361-26-009247. Derived: 12-month figure less the 9-month figure.Report this figure(9.9)Operating income, Q1 FY2025, three months to 2025-03-31−$9.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure(8.9)Operating income, Q2 FY2025, three months to 2025-06-30−$8.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure(8.3)Operating income, Q3 FY2025, three months to 2025-09-30−$8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure(11.5)Operating income, Q4 FY2025, three months to 2025-12-31−$11.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001140361-26-009247. Derived: 12-month figure less the 9-month figure.Report this figure(14.4)Operating income, Q1 FY2026, three months to 2026-03-31−$14.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure(16.5)Operating income, Q2 FY2026, three months to 2026-06-30−$16.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-13, accession 0001140361-23-052749.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-08, accession 0001140361-24-012399. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001140361-26-009247. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001628280-26-054381. Derived: 6-month figure less the 3-month figure.Report this figure0.1Interest expense, Q3 FY2025, three months to 2025-09-30$68.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure0.1Interest expense, Q4 FY2025, three months to 2025-12-31$61.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001140361-26-009247. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2026, three months to 2026-03-31$69.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure0.1Interest expense, Q2 FY2026, three months to 2026-06-30$74.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001628280-26-054381. Derived: 6-month figure less the 3-month figure.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$14.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001140361-24-046045.Report this figure(0.0)Income tax, Q4 FY2023, three months to 2023-12-31−$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-31, accession 0001140361-25-011410. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001140361-25-019266.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-13, accession 0001140361-25-030836.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001140361-26-009247. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001140361-26-009247. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure
Net income$m5.6Net income, Q3 FY2023, three months to 2023-09-30$5.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001140361-24-046045.Report this figure(4.8)Net income, Q4 FY2023, three months to 2023-12-31−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001140361-25-011410. Derived: 12-month figure less the 9-month figure.Report this figure(7.1)Net income, Q1 FY2024, three months to 2024-03-31−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure(7.8)Net income, Q2 FY2024, three months to 2024-06-30−$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure(7.5)Net income, Q3 FY2024, three months to 2024-09-30−$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure(35.1)Net income, Q4 FY2024, three months to 2024-12-31−$35.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001140361-26-009247. Derived: 12-month figure less the 9-month figure.Report this figure(8.2)Net income, Q1 FY2025, three months to 2025-03-31−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure(7.4)Net income, Q2 FY2025, three months to 2025-06-30−$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure(17.5)Net income, Q3 FY2025, three months to 2025-09-30−$17.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure(16.5)Net income, Q4 FY2025, three months to 2025-12-31−$16.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001140361-26-009247. Derived: 12-month figure less the 9-month figure.Report this figure(65.5)Net income, Q1 FY2026, three months to 2026-03-31−$65.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure(8.1)Net income, Q2 FY2026, three months to 2026-06-30−$8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure
Diluted EPS$ per share0.25Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001140361-24-046045.Report this figurenot reported(0.29)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001140361-25-019266.Report this figure(0.30)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001140361-25-030836.Report this figure(0.29)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figurenot reported(0.24)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure(0.12)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure(0.25)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figurenot reported(0.75)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure(0.14)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure
Basic EPS$ per share0.26Basic EPS, Q3 FY2023, three months to 2023-09-30$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001140361-24-046045.Report this figurenot reported(0.29)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001140361-25-019266.Report this figure(0.30)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001140361-25-030836.Report this figure(0.29)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figurenot reported(0.24)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure(0.12)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure(0.25)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figurenot reported(0.75)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure(0.08)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure

Balance sheet

Cash and equivalents$88.8m, Q2 FY2026
Long-term debt$35.3m, Q2 FY2026
Shareholders' equity−$13.0m, Q2 FY2026
Opus Genetics, Inc., balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31period not labelled2026-04-21Q2 FY20262026-06-30
Cash and equivalents$m50.5Cash and equivalents, FY2023, at 2023-12-31$50.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001140361-25-011410.Report this figure47.2Cash and equivalents, Q1 FY2024, at 2024-03-31$47.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0001140361-24-025481.Report this figure41.4Cash and equivalents, Q2 FY2024, at 2024-06-30$41.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001140361-24-037068.Report this figure36.6Cash and equivalents, Q3 FY2024, at 2024-09-30$36.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001140361-24-046045.Report this figure30.3Cash and equivalents, FY2024, at 2024-12-31$30.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001140361-26-009247.Report this figure41.8Cash and equivalents, Q1 FY2025, at 2025-03-31$41.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001140361-25-019266.Report this figure32.4Cash and equivalents, Q2 FY2025, at 2025-06-30$32.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001140361-25-030836.Report this figure30.8Cash and equivalents, Q3 FY2025, at 2025-09-30$30.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure45.1Cash and equivalents, FY2025, at 2025-12-31$45.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure60.0Cash and equivalents, Q1 FY2026, at 2026-03-31$60.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figurenot reported88.8Cash and equivalents, Q2 FY2026, at 2026-06-30$88.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure
Current assets$m53.9Current assets, FY2023, at 2023-12-31$53.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001140361-25-011410.Report this figure51.8Current assets, Q1 FY2024, at 2024-03-31$51.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0001140361-24-025481.Report this figure44.8Current assets, Q2 FY2024, at 2024-06-30$44.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001140361-24-037068.Report this figure40.4Current assets, Q3 FY2024, at 2024-09-30$40.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001140361-24-046045.Report this figure36.6Current assets, FY2024, at 2024-12-31$36.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001140361-26-009247.Report this figure47.9Current assets, Q1 FY2025, at 2025-03-31$47.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001140361-25-019266.Report this figure38.4Current assets, Q2 FY2025, at 2025-06-30$38.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001140361-25-030836.Report this figure35.9Current assets, Q3 FY2025, at 2025-09-30$35.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure50.0Current assets, FY2025, at 2025-12-31$50.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure66.6Current assets, Q1 FY2026, at 2026-03-31$66.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figurenot reported92.7Current assets, Q2 FY2026, at 2026-06-30$92.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure
Total assets$m53.9Total assets, FY2023, at 2023-12-31$53.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001140361-25-011410.Report this figure51.8Total assets, Q1 FY2024, at 2024-03-31$51.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0001140361-24-025481.Report this figure44.8Total assets, Q2 FY2024, at 2024-06-30$44.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001140361-24-037068.Report this figure40.4Total assets, Q3 FY2024, at 2024-09-30$40.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001140361-24-046045.Report this figure36.9Total assets, FY2024, at 2024-12-31$36.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001140361-26-009247.Report this figure48.2Total assets, Q1 FY2025, at 2025-03-31$48.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001140361-25-019266.Report this figure38.7Total assets, Q2 FY2025, at 2025-06-30$38.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001140361-25-030836.Report this figure36.1Total assets, Q3 FY2025, at 2025-09-30$36.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure50.2Total assets, FY2025, at 2025-12-31$50.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure66.8Total assets, Q1 FY2026, at 2026-03-31$66.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figurenot reported93.0Total assets, Q2 FY2026, at 2026-06-30$93.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure
Current liabilities$m4.0Current liabilities, FY2023, at 2023-12-31$4.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001140361-25-011410.Report this figure5.8Current liabilities, Q1 FY2024, at 2024-03-31$5.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0001140361-24-025481.Report this figure4.2Current liabilities, Q2 FY2024, at 2024-06-30$4.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001140361-24-037068.Report this figure6.1Current liabilities, Q3 FY2024, at 2024-09-30$6.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001140361-24-046045.Report this figure11.3Current liabilities, FY2024, at 2024-12-31$11.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001140361-26-009247.Report this figure24.3Current liabilities, Q1 FY2025, at 2025-03-31$24.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001140361-25-019266.Report this figure20.2Current liabilities, Q2 FY2025, at 2025-06-30$20.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001140361-25-030836.Report this figure29.1Current liabilities, Q3 FY2025, at 2025-09-30$29.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure7.8Current liabilities, FY2025, at 2025-12-31$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure9.3Current liabilities, Q1 FY2026, at 2026-03-31$9.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figurenot reported7.6Current liabilities, Q2 FY2026, at 2026-06-30$7.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure
Total liabilities$m4.0Total liabilities, FY2023, at 2023-12-31$4.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001140361-25-011410.Report this figure5.8Total liabilities, Q1 FY2024, at 2024-03-31$5.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0001140361-24-025481.Report this figure4.2Total liabilities, Q2 FY2024, at 2024-06-30$4.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001140361-24-037068.Report this figure6.1Total liabilities, Q3 FY2024, at 2024-09-30$6.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001140361-24-046045.Report this figure11.3Total liabilities, FY2024, at 2024-12-31$11.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001140361-26-009247.Report this figure24.3Total liabilities, Q1 FY2025, at 2025-03-31$24.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001140361-25-019266.Report this figure21.2Total liabilities, Q2 FY2025, at 2025-06-30$21.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001140361-25-030836.Report this figure30.2Total liabilities, Q3 FY2025, at 2025-09-30$30.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure34.9Total liabilities, FY2025, at 2025-12-31$34.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure87.9Total liabilities, Q1 FY2026, at 2026-03-31$87.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figurenot reported106Total liabilities, Q2 FY2026, at 2026-06-30$106.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reported0.0Long-term debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-12, accession 0001140361-26-009247.Report this figurenot reported1.0Long-term debt, Q2 FY2025, at 2025-06-30$1.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-13, accession 0001140361-25-030836.Report this figure1.1Long-term debt, Q3 FY2025, at 2025-09-30$1.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure1.1Long-term debt, FY2025, at 2025-12-31$1.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure1.2Long-term debt, Q1 FY2026, at 2026-03-31$1.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure35.3Long-term debt, period not labelled, at 2026-04-21$35.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure35.3Long-term debt, Q2 FY2026, at 2026-06-30$35.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure
Short-term borrowings$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m49.9Shareholders' equity, FY2023, at 2023-12-31$49.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001140361-26-009247.Report this figure46.1Shareholders' equity, Q1 FY2024, at 2024-03-31$46.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure40.6Shareholders' equity, Q2 FY2024, at 2024-06-30$40.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure34.3Shareholders' equity, Q3 FY2024, at 2024-09-30$34.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure6.7Shareholders' equity, FY2024, at 2024-12-31$6.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure5.1Shareholders' equity, Q1 FY2025, at 2025-03-31$5.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure17.5Shareholders' equity, Q2 FY2025, at 2025-06-30$17.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure6.0Shareholders' equity, Q3 FY2025, at 2025-09-30$6.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure15.3Shareholders' equity, FY2025, at 2025-12-31$15.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure(45.8)Shareholders' equity, Q1 FY2026, at 2026-03-31−$45.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figurenot reported(13.0)Shareholders' equity, Q2 FY2026, at 2026-06-30−$13.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure

Cash flow

Operating cash flow−$11.9m, Q2 FY2026
Opus Genetics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(3.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001140361-24-046045. Derived: 9-month figure less the 6-month figure.Report this figure4.5Operating cash flow, Q4 FY2023, three months to 2023-12-31$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001140361-25-011410. Derived: 12-month figure less the 9-month figure.Report this figure(5.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001140361-25-019266.Report this figure(7.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001140361-25-030836. Derived: 6-month figure less the 3-month figure.Report this figure(5.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001140361-25-041547. Derived: 9-month figure less the 6-month figure.Report this figure(7.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001140361-26-009247. Derived: 12-month figure less the 9-month figure.Report this figure(9.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure(10.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054381. Derived: 6-month figure less the 3-month figure.Report this figure(6.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001140361-25-041547. Derived: 9-month figure less the 6-month figure.Report this figure(9.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001140361-26-009247. Derived: 12-month figure less the 9-month figure.Report this figure(12.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$12.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure(12.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$11.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054381. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)111.38m, Q2 FY2026
Opus Genetics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares20.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3020,498,229 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001140361-23-052749.Report this figure20.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3120,939,607 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-10, accession 0001140361-24-025481.Report this figure21.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3020,959,807 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001140361-24-037068.Report this figure22.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3022,405,995 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001140361-24-046045.Report this figure24.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3124,520,475 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001140361-25-019266.Report this figure25.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3025,827,265 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001140361-25-030836.Report this figure26.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3026,145,080 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure33.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3133,884,920 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure63.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3063,376,392 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure70.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3070,636,887 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001140361-25-041547.Report this figure86.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3186,891,352 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001628280-26-034084.Report this figure111Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30111,384,011 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure

Shares outstanding: 83.20mShares outstanding, period not labelled, at 2026-08-0383,195,823 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-054381.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. Listed shows no prices and gives no investment advice.